2 results
Approved WMORecruiting
Primary- Continuation of treatment- SafetySecondairy- Documentation of tolerability
Approved WMOPending
Main objective:•To compare the progression-free survival of imlunestrant (Arm A) to the standard comparator of Investigator's Choice Endocrine Therapy of either fulvestrant or exemestane (Arm B) in the ITT population•To compare the PFS of Arm…